-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Sees Large Decline in Short Interest
Mayne Pharma Group Limited (OTCMKTS:MAYNF) Sees Large Decline in Short Interest
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 33,300 shares, a decline of 14.4% from the August 31st total of 38,900 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 22.2 days.
Mayne Pharma Group Stock Performance
MAYNF stock opened at $0.18 on Friday. Mayne Pharma Group has a 1-year low of $0.15 and a 1-year high of $0.29. The business has a fifty day moving average price of $0.22 and a 200-day moving average price of $0.20.
Get Mayne Pharma Group alerts:About Mayne Pharma Group
(Get Rating)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Asia, and internationally. The company operates through four segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International.Further Reading
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Rating) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 33,300 shares, a decline of 14.4% from the August 31st total of 38,900 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 22.2 days.
梅恩制药集团有限公司(场外交易市场代码：MAYNF-GET评级)是9月份空头股数股价大幅下降的接受者。截至9月15日，空头股数共有33,300股，较8月31日的38,900股下跌14.4%。基于日均1,500股的成交量，目前的天数与回补比率为22.2天。
Mayne Pharma Group Stock Performance
梅恩制药集团股票表现
MAYNF stock opened at $0.18 on Friday. Mayne Pharma Group has a 1-year low of $0.15 and a 1-year high of $0.29. The business has a fifty day moving average price of $0.22 and a 200-day moving average price of $0.20.
上周五，MAYNF的股票开盘报0.18美元。Mayne Pharma Group的一年低点为0.15美元，一年高位为0.29美元。该业务的50日移动均线价格为0.22美元，200日移动均线价格为0.20美元。
About Mayne Pharma Group
关于梅恩制药集团
(Get Rating)
(获取评级)
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Mayne Pharma Group (MAYNF)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
- 免费获取StockNews.com关于Mayne Pharma Group(MAYNF)的研究报告
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- Keurig Dr Pepper与规模更大的竞争对手可口可乐(Coke&Pepsi)相比如何？
- 让Paychex股票为您努力工作
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受Mayne Pharma Group Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Mayne Pharma Group和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧